CCSD code G4530 – Wireless esophageal pH monitoring (Bravo)

Key takeaways

CCSD code G4530 is catheterless oesophageal pH monitoring, such as the Bravo capsule, in Chapter 10 of the CCSD schedule.

CCSD lists diagnostic OGD (G6500), rigid oesophagoscopy (G1900) and three therapeutic OGD codes as unacceptable combinations with G4530.

Insurers expect the notes to show the indication, PPI washout, capsule placement, recording duration and a signed report.

Pre-authorization rules differ by insurer and policy, so confirm each case through the insurer’s provider portal before the test.

What CCSD code G4530 covers

CCSD code G4530 covers catheterless oesophageal pH monitoring, with Bravo as the named example. The test measures how often acid reaches the esophagus over two days or more. Gastroenterologists and upper gastrointestinal (GI) surgeons order it when symptoms and endoscopy findings leave the diagnosis open.

US practices bill the same capsule study under CPT 91035, so cross-border teams can map one test to both systems.

NICE reviewed the technique in its interventional procedures guidance IPG187. It found the evidence adequate for use with normal consent and audit arrangements. The guidance also notes the capsule suits patients who can’t tolerate a nasal catheter.

How the test runs, step by step

1. The patient stops acid-suppressing medication, such as proton pump inhibitors (PPIs), if the study runs off therapy.
2. The consultant performs an upper endoscopy to examine the esophagus.
3. The capsule is fixed to the esophageal wall by suction and a small pin.
4. The patient goes home wearing a receiver and keeps a symptom diary.
5. After the recording period, the receiver comes back and the data is analyzed.
6. The capsule detaches after a few days and passes naturally.

That endoscopy in step two matters for billing. The next section explains why.

Codes that can’t share the claim

CCSD lists five unacceptable combinations on its G4530 code page. Each one is an upper GI endoscopy code:

• G6500: diagnostic oesophago-gastro-duodenoscopy (OGD), the standard upper endoscopy
• G1900: rigid oesophagoscopy
• G4410: therapeutic OGD with insertion of prosthesis
• G4430: therapeutic OGD with dilatation
• G4440: therapeutic OGD with insertion of PEG/PEJ

A worked example

A patient with persistent heartburn on PPIs is referred for wireless pH testing. The consultant performs an OGD and places the Bravo capsule in the same session.

The tempting claim is G6500 plus G4530. CCSD rules that pairing out, so the claim carries G4530 without the diagnostic OGD. If the endoscopy finds something that changes the plan, look the extra procedure up in our CCSD codes for consultants before you code it.

What the notes need to show

Insurers pay for the test the notes describe. A thin record invites a query, so build the file while the test happens. Check that the record covers each of these points:

• Indication: persistent reflux despite PPIs, atypical symptoms such as chronic cough or noncardiac chest pain, or assessment before anti-reflux surgery.
• Medication status: whether the study ran on or off PPIs, and the date the patient stopped.
• Prior workup: earlier endoscopy, manometry or a failed catheter pH study.
• Placement: the capsule position and the endoscopy findings at placement.
• Recording: the planned and achieved recording duration, such as 48 or 96 hours.
• Report: acid exposure findings, symptom correlation and the consultant’s signed interpretation.

Keep the consent form and the patient’s symptom diary with the report. Both tend to come up when an insurer audits a claim.

Matching the diagnosis code

The ICD-10 code should name the reason for the test, not the result you expect. UK private claims use the WHO ICD-10 classification. These are the usual pairings:

• K21.9: gastro-esophageal reflux disease without esophagitis, for suspected reflux with a normal-looking esophagus.
• R12: heartburn, when the cause is still unconfirmed.
• R13: dysphagia, when swallowing difficulty prompted the referral.

Pick the code that the referral and notes support. Once the report confirms reflux, later episodes can move to the confirmed diagnosis. If the results lead to anti-reflux surgery, that operation bills on its own code, such as G2430 for the transabdominal approach.

Ask before you book

Treat pre-authorization as a question for each patient, not a rule you learn once. Cover differs by insurer, by scheme and by member. So the safe answer always comes from the insurer.

Who confirms cover? The insurer does, through its provider portal or provider helpline. Ask before you set the test date.

What should you send? Send G4530, the ICD-10 code, the indication and a short clinical summary. Record the authorization number and its expiry date.

Where do fees live? Each insurer publishes its own. Check the Aviva fee schedule, the Vitality fee finder, or our guide to Bupa CCSD procedure codes. For AXA Health, WPA and others, use their provider portal.

Does the consultant matter? Yes. Insurers pay recognized consultants, so confirm your recognition is current with each one.

Before you submit

A payable G4530 claim carries four parts and leaves five endoscopy codes off. The panel below puts both on one page.

Then run through this list before each claim goes out:

• The pre-authorization number is on the claim and still in date.
• G4530 appears without G6500, G1900, G4410, G4430 or G4440.
• The ICD-10 code matches the indication in the referral.
• The report is signed and states the recording duration.
• The insurer name and membership number match the patient’s policy.
• The patient knows about any excess before the test.

Mistakes that stall payment

Rejections on this code tend to repeat. These are the ones to design out:

• Billing the endoscopy as well. Adding diagnostic OGD to G4530 breaks a CCSD combination rule.
• A vague indication. “Reflux” alone gives the reviewer little. Name the symptoms, the treatment tried and why pH testing comes next.
• No medication history. If the study ran off PPIs, record when the patient stopped them.
• A missing duration. A report without the recording time looks like a failed study.
• Expired authorization. A pre-authorization that lapses before the test date leaves the claim unsupported.
• Old code lists. Code against the current CCSD schedule, not a list saved years ago.

When a claim comes back

A rejection isn’t the end of the claim. Work through it in this order:

1. Get the reason in writing. A short rejection code rarely tells you enough.
2. Fix admin errors fast. A wrong membership number or missing authorization usually needs a corrected claim, not an appeal.
3. Build the clinical case. For a medical-necessity query, send the referral, indication, prior workup and signed report.
4. Use the insurer’s dispute route. Quote the original claim number and keep a copy of what you sent.
5. Point the patient to the ombudsman if needed. A policyholder can refer a complaint to the Financial Ombudsman Service if the insurer hasn’t resolved it within eight weeks.

Log every rejection reason as it arrives. Over a few months, the log shows which step of your process needs work.

How Pabau keeps G4530 claims moving

pH-study claims usually stall for dull reasons. The authorization number lives in an email, the report sits in another system, and the claim goes out incomplete.

Pabau, the practice management platform we build for private practices, keeps the referral, consent, notes and report on one patient record. Its claims software for specialists pre-fills the claim from that record. It also checks that required fields, such as the membership number and authorization code, are complete before sending.

For UK insurers, claims go out through Pabau’s Healthcode integration, and you track their status in the same place. Pabau doesn’t choose codes for you. Instead, it makes sure the claim you’ve coded leaves complete.

Send complete G4530 claims first time

Pabau keeps pH-study notes, consent and reports on one patient record. It then pre-fills the claim and checks required fields before it goes to Healthcode.

Book a demo

Conclusion

G4530 pays reliably when the file is built before the capsule goes in. Chasing the authorization number or the recording time after a rejection costs weeks you won’t get back.

The combination rule is the easiest one to break, because the endoscopy happens in the same session. So make one habit stick with your coders. Bill the capsule alone, and most appeals never need writing.

Book a demo to see how Pabau keeps pH-study records and insurer claims together on one patient record.

Continue your research

Need a CCSD procedure code reference specific to Bupa? Bupa CCSD procedure codes maps the Bupa fee schedule and explains how Bupa applies CCSD coding for recognized consultants.

Looking to cut claim rejections across your practice? Claims management software covers how Pabau pre-fills, validates and tracks insurer claims.

Billing the same test in the US? CPT code 91035 covers wireless esophageal pH monitoring under US rules.

Does the pH study point to surgery? CCSD code G2430 explains how to bill transabdominal antireflux operations.

Frequently asked questions